Baird upgraded Biogen (NASDAQ: BIIB) from Neutral to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Upgrades

RBC Capital Comments on Biogen (BIIB) and Tecfidera PML Case; Analyst Maintains Outperform RatingOctober 22, 2014 1:27 PM Biogen Idec (BIIB) Says Tecfidera Patient Who Died had Low White Blood Cell CountsOctober 22, 2014 11:52 AM Biogen (BIIB): Deutsche Bank Comments on Recent Weakness And Compares it to Celgene (CELG)October 22, 2014 10:52 AM Biogen Idec (BIIB) Tops Q3 EPS by 31c; Boosts FY14 EPS OutlookOctober 22, 2014 7:06 AM